New pyridine carboxamides

US2020354321A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020354321-A1
Application numberUS-201916966057-A
CountryUS
Kind codeA1
Filing dateJan 29, 2019
Priority dateFeb 7, 2018
Publication dateNov 12, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the use of compounds of formula I, wherein the variables are defined as given in the description and claims. The invention further relates to the compounds I and composition for compounds of formula I.

First claim

Opening claim text (preview).

1 . A compound of formula I wherein X is O, S, NH R 1 is in each case independently selected from hydrogen, halogen, OH, CN, COOH, CONH 2 , NO 2 , SH, NH 2 , NH(C 1 -C 4 -alkyl), N(C 1 -C 4 -alkyl) 2 , NH—SO 2 —R x , C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, C 3 -C 6 -cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein R x is C 1 -C 4 -alkyl, C 1 -C 4 -halogenalkyl, unsubstituted aryl or aryl that is substituted by 1, 2, 3, 4 or 5 substituents R′ independently selected from C 1 -C 4 -alkyl, halogen, OH, CN, C 1 -C 4 -halogenalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenalkoxy; wherein the acyclic moieties of R 1 are unsubstituted or substituted with identical or different groups R 1a which independently of one another are selected from: R 1a halogen, OH, CN, COOH, CONH 2 , C 1 -C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, C 1 -C 4 -halogenalkoxy, C 1 -C 6 -alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or carries 1, 2, 3, 4 or 5 substituents R 11a selected from the group consisting of halogen, OH, C 1 -C 4 -alkyl, C 1 -C 4 -halogenalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenalkoxy; wherein the carbocyclic, heteroaryl and aryl moieties of R 1 are not further substituted or carry 1, 2, 3, 4, 5 or up to the maximum number of identical or different groups R 1b which independently of one another are selected from: R 1b halogen, OH, CN, COOH, CONH 2 , C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, C 1 -C 4 -halogenalkoxy and C 1 -C 6 -alkylthio; R 2 is in each case independently selected from halogen, OH, CN, COOH, CONH 2 , NO 2 , SH, NH 2 , NH(C 1 -C 4 -alkyl), N(C 1 -C 4 -alkyl) 2 , NH(C 2 -C 4 -alkenyl), N(C 2 -C 4 -alkenyl) 2 , NH(C 2 -C 4 -alkynyl), N(C 2 -C 4 -alkynyl) 2 , NH(C 3 -C 6 -cycloalkyl), N(C 3 -C 6 -cycloalkyl) 2 , N(C 1 -C 4 -alkyl)(C 2 -C 4 -alkenyl), N(C 1 -C 4 -alkyl)(C 2 -C 4 -alkynyl), N(C 1 -C 4 -alkyl)(C 3 -C 6 -cycloalkyl), N(C 2 -C 4 -alkenyl)(C 2 -C 4 -alkynyl), N(C 2 -C 4 -alkenyl)(C 3 -C 6 -cycloalkyl), N(C 2 -C 4 -alkynyl)(C 3 -C 6 -cycloalkyl), NH(C(═O)C 1 -C 4 -alkyl), N(C(═O)C 1 -C 4 -alkyl) 2 , NH—SO 2 —R x , S(O) n —C 1 -C 6 -alkyl, S(O) n -aryl, C 1 -C 6 -cycloalkylthio, S(O) n —C 2 -C 6 -alkenyl, S(O) n —C 2 -C 6 -alkynyl, CH(═O), C(═O)C 1 -C 6 -alkyl, C(═O)C 2 -C 6 -alkenyl, C(═O)C 2 -C 6 -alkynyl, C(═O)C 3 -C 6 -cycloalkyl, C(═O)NH(C 1 -C 6 -alkyl), CH(═S), C(═S)C 1 -C 6 -alkyl, C(═S)C 2 -C 6 -alkenyl, C(═S)C 2 -C 6 -alkynyl, C(═S)C 3 -C 6 -cycloalkyl, C(═S)O(C 2 -C 6 -alkenyl), C(═S)O(C 2 -C 6 -alkynyl), C(═S)O(C 3 -C 7 -cycloalkyl), C(═S)NH(C 1 -C 6 -alkyl), C(═S)NH(C 2 -C 6 -alkenyl), C(═S)NH(C 2 -C 6 -alkynyl), C(═S)NH(C 3 -C 7 -cycloalkyl), C(═S)N(C 1 -C 6 -alkyl) 2 , C(═S)N(C 2 -C 6 -alkenyl) 2 , C(═S)N(C 2 -C 6 -alkynyl) 2 , C(═S)N(C 3 -C 7 -cycloalkyl) 2 , C 1 -C 6 -alkyl, C 1 -C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, OR′, C 3 -C 6 -cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein R x is as defined above; R Y is C 1 -C 6 -alkyl, C 1 -C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, phenyl and phenyl-C 1 -C 6 -alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C 1 -C 4 -alkyl, C 1 -C 4 -halogenalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenalkoxy; wherein the acyclic moieties of R 2 are unsubstituted or substituted by groups R 2a which independently of one another are selected from: R 2a halogen, OH, CN, COOH, CONH 2 , C 1 -C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, C 1 -C 4 -halogenalkoxy, C 1 -C 6 -alkylthio and phenoxy, wherein the phenyl group is unsubstituted or substituted by substituents R 91a selected from the group consisting of halogen, OH, C 1 -C 4 -alkyl, C 1 -C 4 -halogenalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -halogenalkoxy; wherein the carbocyclic, heteroaryl and aryl moieties of R 2 are unsubstituted or substituted by groups R 3b which independently of one another are selected from: R 2b halogen, OH, CN, COOH, CONH 2 , C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, C 1 -C 4 -halogenalkoxy and C 1 -C 6 -alkylthio; and wherein n is defined as above; R 3 is in each case independently selected from the substituents as defined for R 2 , wherein the possible substituents for R 3 are R 3a and R 3b , respectively, which correspond to R 2a and R 2b , respectively; R 2 , R 3 together with the carbon atoms to which they are bound form a five-, six-, or seven-membered carbo-, heterocyclic or heteroaromatic ring; wherein the heterocyclic or heteroaromatic ring contains 1, 2, 3 or 4 heteroatoms selected from N, O and S, wherein N may carry one substituent R N selected from C 1 -C 4 -alkyl, C 1 -C 4 -halogenalkyl and SO 2 Ph, wherein Ph is unsubstituted or substituted by substituents selected from C 1 -C 4 -alkyl, halogen, C 1 -C 4 -halogenalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenalkoxy, and CN; and wherein S may be in the form of its oxide SO or SO 2 ; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(═O) and C(═S); and wherein the carbo-, heterocyclic or heteroaromatic ring is substituent by (R 23 ) m , wherein m is 0, 1, 2, 3 or 4; R 23 is in each case independently selected from halogen, OH, CN, COOH, CONH 2 , NO 2 , SH, NH 2 , NH(C 1 -C 4 -alkyl), N(C 1 -C 4 -alkyl) 2 , NH—SO 2 —R x , C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, C 3 -C 6 -cycloalkyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl and aryl; wherein the heterocycle and heteroaryl contains 1, 2 or 3 heteroatoms selected from N, O and S; and wherein in each case one or two CH 2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(═O) and C(═S); and wherein R x is as defined above; wherein the acyclic moieties of R 23 are unsubstituted or carry 1, 2, 3 or up to the maximum possible number of identical or different groups R 23a which independently of one another are selected from: R 23a halogen, OH, CN, COOH, CONH 2 , C 1 -C 6 -alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, C 1 -C 4 -halogenalkoxy, C 1 -C 6 -alkylthio and phenoxy, wherein the phenyl group is unsubstituted or unsubstituted or substituted with R 91a selected from the group consisting of halogen, OH, C 1 -C 4 -alkyl, C 1 -C 4 -halogenalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenalkoxy, CN, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, C 1 -C 4 -alkylthio; wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R 23 are unsubstituted or substituted with identical or different groups R 23 which independently of one another are selected from: R 23b halogen, OH, CN, COOH, CONH 2 , C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -halogenalkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halogencycloalkyl, C 1 -C 4 -halogenalkoxy, and C 1 -C 6 -alkylthio; R 4 is in each case independently selected from hydrogen, halogen, OH, CN, COOH, CONH 2 , NO 2 , SH, NH 2 , NH(C 1 -C 4 -alkyl), N(C 1 -C 4 -alkyl) 2 , NH—SO 2 —R x , C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, C 3 -C 6 -cycloalkyl, five- or six-

Assignees

Inventors

Classifications

  • linked by a chain containing hetero atoms as chain links · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020354321A1 cover?
The present invention relates to the use of compounds of formula I, wherein the variables are defined as given in the description and claims. The invention further relates to the compounds I and composition for compounds of formula I.
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C07D401/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Nov 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).